Yskert von Kodolitsch
Overview
Explore the profile of Yskert von Kodolitsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
1582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Csengeri D, Unger E, Weimann J, Huntgeburth M, von Kodolitsch Y, Zeller T, et al.
Cardiovasc Diagn Ther
. 2025 Jan;
14(6):1058-1069.
PMID: 39790199
Background: Cardiovascular disease (CVD) remains the leading cause of death in pregnant and peripartal women in western countries. Physiological changes during pregnancy can lead to cardiovascular complications in the mother;...
2.
Aldag M, Nana P, Panuccio G, Torrealba J, Schofer N, Spanos K, et al.
J Vasc Surg
. 2024 Nov;
PMID: 39586366
Background: This study aimed to evaluate the suitability of a coronary-branched ascending aortic endograft, paired with aortic valve (AV) prosthesis (Endo-Bentall), for the endovascular repair of ascending aortic aneurysms. Methods:...
3.
Kneussel J, Olfe J, Stark V, von Kodolitsch Y, Kozlik-Feldmann R, Friehs I, et al.
Pediatr Res
. 2024 Oct;
PMID: 39379624
Background: Marfan syndrome (MFS) is associated with cardiovascular complications, particularly valvulopathies; however, its association with primary cardiomyopathy remains unclear. Methods: This retrospective cohort study examined the cardiomyopathy characteristics (CMCs) in...
4.
Claus J, Schoof L, Mir T, Kammal A, Schon G, Kutsche K, et al.
J Thorac Cardiovasc Surg
. 2024 Sep;
PMID: 39306029
Background: Marfan syndrome (MFS) guidelines recommend optimal pharmacologic therapy (OPT) and replacement of the ascending aorta (RAA) at 5.0 cm in diameter to prevent acute type A aortic dissection (ATAAD)...
5.
Lenz A, Bahr F, Riedel C, Wright F, Sinn M, Zhang S, et al.
Eur Radiol
. 2024 Sep;
PMID: 39283357
Objectives: 4D flow MRI-derived variables from Marfan patients are highly heterogeneous. Our aim was to identify distinct Marfan patient subgroups based on aortic 4D flow MRI and Z-score for stratification...
6.
Nana P, Spanos K, Panuccio G, Rohlffs F, Detter C, von Kodolitsch Y, et al.
J Vasc Surg
. 2024 Apr;
80(3):621-629.e3.
PMID: 38580160
Objective: Fenestrated and branched thoracic endovascular repair (f/bTEVAR) have been successfully applied in patients with diverse aortic arch pathologies. The aim of this study is to present the early and...
7.
Freilinger S, Kaemmerer H, Pittrow R, Achenbach S, Baldus S, Dewald O, et al.
BMC Cardiovasc Disord
. 2024 Mar;
24(1):181.
PMID: 38532336
Background: Adults with congenital heart defects (ACHD) globally constitute a notably medically underserved patient population. Despite therapeutic advancements, these individuals often confront substantial physical and psychosocial residua or sequelae, requiring...
8.
Stark V, Olfe J, Diaz-Gil D, von Kodolitsch Y, Kozlik-Feldmann R, Reincke J, et al.
Front Pediatr
. 2024 Feb;
12:1276215.
PMID: 38379908
Introduction: Transforming growth factor β (TGFβ) metabolism plays an important role in the pathogenesis of Marfan syndrome (MFS). Accordingly, drug therapy uses TGFβ receptor blockade to slow down the cardiovascular...
9.
von Kodolitsch Y, Virdis A, Debus E
Cardiovasc Diagn Ther
. 2023 Nov;
13(5):914-916.
PMID: 37941841
No abstract available.
10.
von Kodolitsch Y, Kubisch C, Carrel T
Lancet
. 2023 Nov;
402(10413):1626.
PMID: 37925199
No abstract available.